For the more than 25 million people in the U.S. who have diabetes, tracking and managing the disease for optimal health is a time intensive but highly important process. Monitoring glucose levels, for instance, allows patients to keep tabs on blood sugar to avoid the problematic complications that can result from high or low levels. And now, there’s greater assistance being offered through emerging broadband-backed technology innovations.
As the Wall Street Journal recently reported, two new mobile glucose monitoring systems can help diabetics more easily monitor their blood levels, which help inform diet, exercise and medication. The iHealth Wireless Smart Gluco-Monitoring System and the OneTouch VerioSync Meter have similar objectives and capabilities. Both utilize an app that collects and analyzes readings, sends reports via the Internet to the patient’s physician, and shows the patient’s health status over time. In addition, the VerioSync app allows the user to email screenshots or tables of results, and iHealth’s emails can be opened in spreadsheet format. While the system still requires regular finger sticks, the information is organized and displayed digitally, communicating volumes about a patient’s health status.
Internet tools make additional important contributions to those living with diabetes. For example, the WellDoc® DiabetesManager® system integrates online education with diabetes self-care and connects patients to doctors as well. The software looks at a patient's glucose levels and provides tailored feedback and education to promote healthier lifestyle choices. Wearable devices like FitBit and food tracking apps from LIVESTRONG and others also help promote diet and exercise recommended by the nation’s leading experts on the treatment and prevention of this disease.
These technologies not only contribute in a significant way to the health and wellbeing of the millions of Americans diagnosed with diabetes, but also provide a fascinating preview of what e-health can help accomplish in the years ahead.